Intrinsic Therapeutics, Inc. Announces New Management Team Member

WOBURN, Mass.-- September 29, 2008 --Intrinsic Therapeutics, Inc., a privately held company, announced the addition of a new management team member to lead the key role of Clinical/Regulatory and Quality. Mr. Barry Sands was recently added to the management team as the Vice President of Clinical/Regulatory and Quality. Barry has a very deep understanding in the spinal area from spending time in both large and small companies managing and directing key activities in all three disciplines. Barry has also spent time as a reviewer with the Food and Drug Administration. Prior to joining Intrinsic Therapeutics, Barry was the Vice President of Clinical/Regulatory and Quality at Impliant, Inc.

About Intrinsic Therapeutics
Intrinsic Therapeutics, Inc., based in Woburn, MA, is a medical device company focused on developing innovative therapies that address the spine market's many unmet clinical needs. The company's first product is a revolutionary spinal implant that is being developed to treat the most common causes of sciatica and low back pain.

For more information please contact:
Intrinsic Therapeutics
Scott LeBlanc, Director of Finance
(781) 932-0222
finance@intrinsic-therapeutics.com